$1.02 Billion is the total value of Logos Global Management LP's 53 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 98.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ALXO | ALX ONCOLOGY HLDGS INC | $232,796,000 | -14.5% | 3,156,981 | 0.0% | 22.72% | -2.6% | |
| OLMA | OLEMA PHARMACEUTICALS INC | $124,222,000 | -31.0% | 3,743,875 | 0.0% | 12.12% | -21.4% | |
| DSGN | New | DESIGN THERAPEUTICS INC | $81,702,000 | – | 2,732,501 | +100.0% | 7.97% | – |
| DYN | Buy | DYNE THERAPEUTICS INC | $49,764,000 | +47.7% | 3,204,392 | +99.7% | 4.86% | +68.2% |
| TIL | New | INSTIL BIO INC | $46,319,000 | – | 1,846,850 | +100.0% | 4.52% | – |
| NKTX | Sell | NKARTA INC | $41,483,000 | -59.9% | 1,260,877 | -25.0% | 4.05% | -54.3% |
| FMTX | Buy | FORMA THERAPEUTICS HLDGS INC | $39,508,000 | -19.1% | 1,410,000 | +0.7% | 3.86% | -7.9% |
| EWTX | New | EDGEWISE THERAPEUTICS INC | $34,346,000 | – | 1,056,812 | +100.0% | 3.35% | – |
| KNTE | Buy | KINNATE BIOPHARMA INC | $29,122,000 | +28.5% | 934,602 | +64.1% | 2.84% | +46.3% |
| RPTX | Buy | REPARE THERAPEUTICS INC | $27,621,000 | +19.0% | 900,000 | +33.0% | 2.70% | +35.5% |
| KRTX | Buy | KARUNA THERAPEUTICS INC | $24,046,000 | +97.2% | 200,000 | +66.7% | 2.35% | +124.6% |
| BCYC | New | BICYCLE THERAPEUTICS PLCsponsored ads | $23,896,000 | – | 800,000 | +100.0% | 2.33% | – |
| ATHA | Buy | ATHIRA PHARMA INC | $18,599,000 | -42.7% | 1,010,812 | +6.6% | 1.82% | -34.8% |
| BTAI | Sell | BIOXCEL THERAPEUTICS INC | $17,264,000 | -13.1% | 400,000 | -7.0% | 1.68% | -1.1% |
| CGEM | New | CULLINAN ONCOLOGY INC | $17,229,000 | – | 413,458 | +100.0% | 1.68% | – |
| CYTK | New | CYTOKINETICS INC | $16,282,000 | – | 700,000 | +100.0% | 1.59% | – |
| TPTX | New | TURNING POINT THERAPEUTICS I | $13,243,000 | – | 140,000 | +100.0% | 1.29% | – |
| COGT | Sell | UNUM THERAPEUTICS INC | $12,472,000 | -42.2% | 1,420,500 | -26.0% | 1.22% | -34.2% |
| IKNA | New | IKENA ONCOLOGY INC | $11,861,000 | – | 419,853 | +100.0% | 1.16% | – |
| ALGS | Sell | ALIGOS THERAPEUTICS INC | $10,837,000 | -35.4% | 476,547 | -21.4% | 1.06% | -26.4% |
| KYMR | Buy | KYMERA THERAPEUTICS INC | $10,139,000 | +47.4% | 260,920 | +135.2% | 0.99% | +67.6% |
| VINC | New | VINCERX PHARMA INC | $9,264,000 | – | 480,000 | +100.0% | 0.90% | – |
| CMPS | Sell | COMPASS PATHWAYS PLCsponsored ads | $9,205,000 | -35.6% | 250,000 | -16.7% | 0.90% | -26.7% |
| VRDN | New | VIRIDIAN THERAPEUTICS INC | $9,191,000 | – | 550,000 | +100.0% | 0.90% | – |
| ASLN | New | ASLAN PHARMACEUTICALS LTDads | $7,705,000 | – | 2,300,000 | +100.0% | 0.75% | – |
| ISEE | New | IVERIC BIO INC | $7,416,000 | – | 1,200,000 | +100.0% | 0.72% | – |
| KNSA | New | KINIKSA PHARMACEUTICALS LTD | $7,404,000 | – | 400,000 | +100.0% | 0.72% | – |
| LABP | New | LANDOS BIOPHARMA INC | $7,068,000 | – | 734,000 | +100.0% | 0.69% | – |
| PMVP | Buy | PMV PHARMACEUTICALS INC | $6,578,000 | +6.9% | 200,000 | +100.0% | 0.64% | +21.8% |
| HARP | New | HARPOON THERAPEUTICS INC | $6,276,000 | – | 300,000 | +100.0% | 0.61% | – |
| SBTX | Sell | SILVERBACK THERAPEUTICS INC | $5,454,000 | -60.8% | 125,000 | -58.3% | 0.53% | -55.4% |
| RACA | THERAPEUTICS ACQUISITION COR | $5,255,000 | -24.5% | 500,000 | 0.0% | 0.51% | -14.1% | |
| BOLT | New | BOLT BIOTHERAPEUTICS INC | $4,937,000 | – | 150,000 | +100.0% | 0.48% | – |
| KZR | New | KEZAR LIFE SCIENCES INC | $4,768,000 | – | 800,000 | +100.0% | 0.46% | – |
| ANNX | ANNEXON INC | $4,444,000 | +11.2% | 159,622 | 0.0% | 0.43% | +26.9% | |
| VIRX | New | VIRACTA THERAPEUTICS INC | $4,348,000 | – | 470,000 | +100.0% | 0.42% | – |
| CCCC | Sell | C4 THERAPEUTICS INC | $4,177,000 | -73.6% | 112,928 | -76.4% | 0.41% | -69.9% |
| LRMR | Sell | LARIMAR THERAPEUTICS INC | $3,360,000 | -78.1% | 230,000 | -67.8% | 0.33% | -75.0% |
| HSAQ | HEALTH SCIENCES ACQ CORP 2 | $3,357,000 | -12.6% | 300,000 | 0.0% | 0.33% | -0.3% | |
| HRMY | HARMONY BIOSCIENCES HLDGS IN | $3,304,000 | -8.6% | 100,000 | 0.0% | 0.32% | +3.9% | |
| RACB | New | RESEARCH ALLIANCE CORP II | $3,075,000 | – | 300,000 | +100.0% | 0.30% | – |
| LHDX | New | LUCIRA HEALTH INC | $3,025,000 | – | 250,000 | +100.0% | 0.30% | – |
| FSII | New | FS DEVELOPMENT CORP II | $2,988,000 | – | 300,000 | +100.0% | 0.29% | – |
| DCPH | New | DECIPHERA PHARMACEUTICALS IN | $2,780,000 | – | 62,000 | +100.0% | 0.27% | – |
| CNTB | New | CONNECT BIOPHARMA HLDGS LTDads | $2,775,000 | – | 150,000 | +100.0% | 0.27% | – |
| EAR | EARGO INC | $2,498,000 | +11.5% | 50,000 | 0.0% | 0.24% | +27.1% | |
| ELDN | New | ELEDON PHARMACEUTICALS INC | $2,398,000 | – | 224,071 | +100.0% | 0.23% | – |
| BCTG | BCTG ACQUISITION CORP | $2,224,000 | -2.8% | 200,000 | 0.0% | 0.22% | +10.7% | |
| PASG | Sell | PASSAGE BIO INC | $2,185,000 | -75.2% | 125,010 | -63.7% | 0.21% | -71.8% |
| ARYD | New | ARYA SCIENCES ACQU CORP IVcl a | $2,095,000 | – | 200,000 | +100.0% | 0.20% | – |
| HLXA | HELIX ACQUISITION CORP | $2,040,000 | -10.3% | 200,000 | 0.0% | 0.20% | +2.1% | |
| NUVBWS | New | NUVATION BIO INC*w exp 07/07/202 | $178,000 | – | 66,666 | +100.0% | 0.02% | – |
| CEREW | CEREVEL THERAPEUTICS HLDNG I*w exp 06/09/202 | $144,000 | -23.4% | 33,333 | 0.0% | 0.01% | -12.5% | |
| GBIO | Exit | GENERATION BIO CO | $0 | – | -17,000 | -100.0% | -0.04% | – |
| FSDC | Exit | FS DEV CORP | $0 | – | -100,000 | -100.0% | -0.09% | – |
| AMTI | Exit | APPLIED MOLECULAR TRANS INC | $0 | – | -42,847 | -100.0% | -0.11% | – |
| CERE | Exit | CEREVEL THERAPEUTICS HLDNG I | $0 | – | -100,000 | -100.0% | -0.14% | – |
| TVTX | Exit | TRAVERE THERAPEUTICS INC | $0 | – | -61,152 | -100.0% | -0.14% | – |
| PLRX | Exit | PLIANT THERAPEUTICS INC | $0 | – | -76,426 | -100.0% | -0.15% | – |
| OPT | Exit | OPTHEA LTDsponsored ads | $0 | – | -160,000 | -100.0% | -0.15% | – |
| PANAU | Exit | PANACEA ACQUISITION CORPunit 99/99/9999 | $0 | – | -200,000 | -100.0% | -0.22% | – |
| OM | Exit | OUTSET MED INC | $0 | – | -50,000 | -100.0% | -0.24% | – |
| ITOS | Exit | ITEOS THERAPEUTICS INC | $0 | – | -100,000 | -100.0% | -0.29% | – |
| NVUS | Exit | NOVUS THERAPEUTICS INC | $0 | – | -224,071 | -100.0% | -0.30% | – |
| BMYRT | Exit | BRISTOL-MYERS SQUIBB COright 99/99/9999 | $0 | – | -5,050,000 | -100.0% | -0.30% | – |
| PCVX | Exit | VAXCYTE INC | $0 | – | -140,000 | -100.0% | -0.32% | – |
| BDTX | Exit | BLACK DIAMOND THERAPEUTICS I | $0 | – | -123,465 | -100.0% | -0.34% | – |
| EYPT | Exit | EYEPOINT PHARMACEUTICALS INC | $0 | – | -699,999 | -100.0% | -0.40% | – |
| LUNG | Exit | PULMONX CORP | $0 | – | -75,000 | -100.0% | -0.44% | – |
| STTK | Exit | SHATTUCK LABS INC | $0 | – | -121,562 | -100.0% | -0.55% | – |
| EPIX | Exit | ESSA PHARMA INC | $0 | – | -550,000 | -100.0% | -0.56% | – |
| NRIX | Exit | NURIX THERAPEUTICS INC | $0 | – | -230,297 | -100.0% | -0.65% | – |
| VINCU | Exit | VINCERA PHARMA INCunit 12/24/2025 | $0 | – | -400,000 | -100.0% | -0.66% | – |
| MGEN | Exit | MIRAGEN THERAPEUTICS INC | $0 | – | -550,000 | -100.0% | -0.78% | – |
| KALV | Exit | KALVISTA PHARMACEUTICALS INC | $0 | – | -490,000 | -100.0% | -0.80% | – |
| CRIS | Exit | CURIS INC | $0 | – | -1,200,000 | -100.0% | -0.84% | – |
| CALT | Exit | CALLIDITAS THERAPEUTICS ABsponsered ads | $0 | – | -300,000 | -100.0% | -0.86% | – |
| MRTX | Exit | MIRATI THERAPEUTICS INC | $0 | – | -50,000 | -100.0% | -0.94% | – |
| ABCL | Exit | ABCELLERA BIOLOGICS INC | $0 | – | -300,000 | -100.0% | -1.04% | – |
| IGMS | Exit | IGM BIOSCIENCES INC | $0 | – | -150,000 | -100.0% | -1.14% | – |
| RNA | Exit | AVIDITY BIOSCIENCES INC | $0 | – | -671,454 | -100.0% | -1.47% | – |
| BHVN | Exit | BIOHAVEN PHARMACTL HLDG CO Lcall | $0 | – | -200,000 | -100.0% | -1.47% | – |
| APLS | Exit | APELLIS PHARMACEUTICALS INC | $0 | – | -300,000 | -100.0% | -1.47% | – |
| KROS | Exit | KEROS THERAPEUTICS INC | $0 | – | -450,000 | -100.0% | -2.72% | – |
| TGTX | Exit | TG THERAPEUTICS INC | $0 | – | -850,000 | -100.0% | -3.79% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-17
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CYTOKINETICS INC | 14 | Q3 2023 | 12.6% |
| KARUNA THERAPEUTICS INC | 14 | Q3 2023 | 5.6% |
| ALX ONCOLOGY HLDGS INC | 13 | Q3 2023 | 23.3% |
| DYNE THERAPEUTICS INC | 13 | Q3 2023 | 4.9% |
| APELLIS PHARMACEUTICALS INC | 12 | Q3 2023 | 12.4% |
| OLEMA PHARMACEUTICALS INC | 12 | Q3 2023 | 15.4% |
| DESIGN THERAPEUTICS INC | 11 | Q3 2023 | 8.0% |
| NUVATION BIO INC | 11 | Q3 2023 | 0.0% |
| BICYCLE THERAPEUTICS PLC | 10 | Q2 2023 | 5.7% |
| IDEAYA BIOSCIENCES INC | 9 | Q3 2023 | 9.5% |
View Logos Global Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aeglea BioTherapeutics, Inc. | July 18, 2023 | 6,350,000 | 8.1% |
| BICYCLE THERAPEUTICS plc | February 14, 2023 | 1,435,000 | 4.8% |
| Dyne Therapeutics, Inc. | February 14, 2023 | 2,150,000 | 4.1% |
| Design Therapeutics, Inc. | March 31, 2022 | 2,797,501 | 5.0% |
| IDEAYA Biosciences, Inc. | March 18, 2022 | 2,650,000 | 6.9% |
| Aligos Therapeutics, Inc. | February 14, 2022 | ? | ? |
| Cogent Biosciences, Inc. | February 14, 2022 | 150,000 | 0.4% |
| Kezar Life Sciences, Inc. | February 14, 2022 | 1,450,000 | 3.0% |
| Nkarta, Inc. | February 14, 2022 | ? | ? |
| Viridian Therapeutics, Inc.\DE | February 14, 2022 | ? | ? |
View Logos Global Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-01 |
| SC 13G | 2024-02-22 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G | 2024-01-22 |
| SC 13G | 2024-01-22 |
| SC 13G | 2024-01-02 |
View Logos Global Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.